Legal & General Group Plc Purchases Shares of 81,453 Ingevity Corporation $NGVT

Legal & General Group Plc acquired a new stake in Ingevity Corporation (NYSE:NGVT) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 81,453 shares of the company’s stock, valued at approximately $6,082,000. Legal & General Group Plc owned 0.24% of Ingevity as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently modified their holdings of the company. Los Angeles Capital Management LLC increased its holdings in Ingevity by 94.2% in the 4th quarter. Los Angeles Capital Management LLC now owns 30,877 shares of the company’s stock worth $1,827,000 after buying an additional 14,975 shares during the period. Pacer Advisors Inc. purchased a new position in Ingevity during the 4th quarter worth approximately $9,660,000. Principal Financial Group Inc. lifted its stake in Ingevity by 4.0% during the 1st quarter. Principal Financial Group Inc. now owns 678,037 shares of the company’s stock valued at $48,297,000 after acquiring an additional 25,800 shares during the period. Illinois Municipal Retirement Fund acquired a new stake in Ingevity during the 1st quarter valued at approximately $1,465,000. Finally, Bessemer Group Inc. boosted its holdings in shares of Ingevity by 465.9% in the 1st quarter. Bessemer Group Inc. now owns 314,739 shares of the company’s stock valued at $22,419,000 after acquiring an additional 259,124 shares during the last quarter. 91.59% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on NGVT shares. Weiss Ratings upgraded shares of Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. Wall Street Zen lowered shares of Ingevity from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 1st. Two investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $80.00.

Insiders Place Their Bets

In related news, CEO David H. Li sold 5,000 shares of the firm’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $75.83, for a total transaction of $379,150.00. Following the sale, the chief executive officer owned 120,636 shares in the company, valued at approximately $9,147,827.88. This trade represents a 3.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Ryan C. Fisher sold 2,709 shares of the firm’s stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $73.72, for a total transaction of $199,707.48. Following the sale, the senior vice president owned 15,722 shares in the company, valued at approximately $1,159,025.84. This represents a 14.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 17,801 shares of company stock worth $1,347,481 over the last three months. 0.88% of the stock is currently owned by insiders.

Ingevity Trading Up 0.8%

Shares of NYSE:NGVT opened at $69.03 on Thursday. Ingevity Corporation has a 12-month low of $45.85 and a 12-month high of $79.29. The company has a market capitalization of $2.37 billion, a PE ratio of 46.96 and a beta of 1.17. The business has a 50 day moving average of $73.27 and a two-hundred day moving average of $71.67. The company has a current ratio of 1.61, a quick ratio of 1.15 and a debt-to-equity ratio of 22.52.

Ingevity (NYSE:NGVT) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.41. The business had revenue of $314.10 million for the quarter, compared to analysts’ expectations of $312.20 million. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, analysts forecast that Ingevity Corporation will post 5.4 EPS for the current year.

Ingevity Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.